Skip to content

Alternative (Intermittent) Vs Standard (Continous) Treatment (Phototherapy) Methods For Jaundice in Newborns

Intermittent versus Continuous phototherapy for neonatal nonhemolytic hyperbilirubinemia in neonates 28 to 34 weeks of gestational age A non inferiority randomized control trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068787
Enrollment
90
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P599- Neonatal jaundice, unspecified

Interventions

Intervention1: Intermittent Phototherapy: Timed,6hourly interrupted phototherapy for neonatal phototherapy- To be given for 12-24 hours till resolution of jaundice i.e. Serum Bilirubin falls below ph

Sponsors

Sri Ramachandra Medical College Porur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates 28- 34 weeks gestation with non-hemolytic jaundice

Exclusion criteria

Exclusion criteria: Septic Shock with systemic instability Major congenital and chromosomal anomalies Severe IVH Culture proven Meningitis Babies on phototherapy for indication other than hyperbilirubinenemia

Design outcomes

Primary

MeasureTime frame
The rate of fall of serum bilirubin values during the treatment durationTimepoint: From the time of starting Phototherapy to 24 hours after

Secondary

MeasureTime frame
I. Duration of Phototherapy received to treat non hemolytic hyperbilirubinemia II. Incidence of “IPT Non responders ? III. KMC duration IV. Weight loss patterns V. Feed intolerance VI. Nurse Satisfaction Score VII. Newborn Skin Condition Scores Timepoint: I. At end of study II. At end of study period III. Daily IV. Daily V. Daily VI. One time during treatment period VII. One time after receiving cumulative at least 24 hours of phototherapy

Countries

India

Contacts

Public ContactDr Ishita Singh

Sri Ramachandra Medical College

draprakash1@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026